{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:07:02Z","timestamp":1788336422583,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA107399"],"award-info":[{"award-number":["P50CA107399"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA213131"],"award-info":[{"award-number":["R01CA213131"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA229510-01"],"award-info":[{"award-number":["R01 CA229510-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["2325-19"],"award-info":[{"award-number":["2325-19"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jid.2021.08.447","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T20:18:05Z","timestamp":1636575485000},"page":"603-612.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PA","title":["MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell Lymphoma"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9230-2270","authenticated-orcid":false,"given":"Zhen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6209-065X","authenticated-orcid":false,"given":"Renee J.","family":"Estephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-1671","authenticated-orcid":false,"given":"Xiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8354-8503","authenticated-orcid":false,"given":"Chingyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3698-9784","authenticated-orcid":false,"given":"Yate-Ching","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-0913","authenticated-orcid":false,"given":"Hanjun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5152-6692","authenticated-orcid":false,"given":"Sung Hee","family":"Kil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9055-4757","authenticated-orcid":false,"given":"Corey","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6947-2546","authenticated-orcid":false,"given":"Daniel","family":"Schmolze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-6894","authenticated-orcid":false,"given":"James F.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-0098","authenticated-orcid":false,"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-3223","authenticated-orcid":false,"given":"Jianhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6003-1816","authenticated-orcid":false,"given":"Marcin","family":"Kortylewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-7724","authenticated-orcid":false,"given":"Steven T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-5809","authenticated-orcid":false,"given":"Christiane","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.08.447_bib1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1080\/10428194.2018.1564827","article-title":"Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sezary syndrome","volume":"60","author":"Anzengruber","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jid.2021.08.447_bib3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1126\/science.278.5344.1803","article-title":"Specific inhibition of Stat3 signal transduction by PIAS3","volume":"278","author":"Chung","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jid.2021.08.447_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/gcc.22725","article-title":"Role of miRNAs in immune responses and immunotherapy in cancer","volume":"58","author":"Cortez","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2021.08.447_bib5","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973\u20132002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2021.08.447_bib6","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.2019000889","article-title":"EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2","volume":"134","author":"Cristino","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.08.447_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10254-003-0015-z","article-title":"Negative regulation of cytokine signaling by CIS\/SOCS family proteins and their roles in inflammatory diseases","volume":"149","author":"Hanada","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.jid.2021.08.447_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/gutjnl-2015-311238","article-title":"Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer","volume":"66","author":"Jang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jid.2021.08.447_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2021.08.447_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005970","article-title":"CellProfiler 3.0: next-generation image processing for biology","volume":"16","author":"McQuin","year":"2018","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jid.2021.08.447_bib11","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","article-title":"MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome","volume":"2","author":"Narducci","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2021.08.447_bib12","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","article-title":"Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression","volume":"13","author":"Netchiporouk","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jid.2021.08.447_bib13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.08.447_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00403-020-02062-5","article-title":"The polymorphisms of IL-6\/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility","volume":"313","author":"Olszewska","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2021.08.447_bib15","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1111\/febs.15000","article-title":"Immunomodulatory microRNAs in cancer: targeting immune checkpoints and the tumor microenvironment","volume":"286","author":"Omar","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.jid.2021.08.447_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1541-7786.MCR-14-0352","article-title":"RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma","volume":"13","author":"Pal","year":"2015","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jid.2021.08.447_bib18","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2018-99-119861","article-title":"Phase 1 trial of cobomarsen, an inhibitor of Mir-155, in cutaneous T cell lymphoma","volume":"132","author":"Querfeld","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.08.447_bib19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2326-6066.CIR-17-0270","article-title":"Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile","volume":"6","author":"Querfeld","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jid.2021.08.447_bib20","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.08.447_bib21","first-page":"7207","article-title":"MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma [published correction appears in Anticancer Res 2015;35:1219]","volume":"34","author":"Ralfkiaer","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jid.2021.08.447_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CCO.0000000000000243","article-title":"Tumor microenvironment in mycosis fungoides and Sezary syndrome","volume":"28","author":"Rubio Gonzalez","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jid.2021.08.447_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jid.2021.08.447_bib25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1111\/febs.14030","article-title":"Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics","volume":"284","author":"Smolle","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.jid.2021.08.447_bib26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.08.447_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","article-title":"MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in S\u00e9zary syndrome","volume":"131","author":"van der Fits","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.08.447_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","article-title":"miRNA expression profiling of mycosis fungoides","volume":"5","author":"van Kester","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jid.2021.08.447_bib29","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1200\/JCO.2001.19.23.4322","article-title":"CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas ligand, and killing inhibitory receptors and their relationship with clinical behavior","volume":"19","author":"Vermeer","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.08.447_bib30","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M509595200","article-title":"The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling","volume":"281","author":"Wormald","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2021.08.447_bib31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/ijms17091467","article-title":"Aberrant JAK\/STAT signaling suppresses TFF1 and TFF2 through epigenetic silencing of GATA6 in gastric cancer","volume":"17","author":"Wu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2021.08.447_bib32","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/MCB.19.3.2416","article-title":"Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak\/STAT pathway","volume":"19","author":"You","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2021.08.447_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jid.2021.08.447_bib34","doi-asserted-by":"crossref","first-page":"E8379","DOI":"10.1073\/pnas.1608461113","article-title":"Molecular profiling of single circulating tumor cells from lung cancer patients","volume":"113","author":"Park","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.08.447_bib35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm942","article-title":"Ex\u00a0vivo identification, isolation and analysis of tumor-cytolytic T cells","volume":"9","author":"Rubio","year":"2003","journal-title":"Nat Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21024799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21024799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:24:32Z","timestamp":1758302672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21024799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022202X21024799"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.08.447","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741169661.793590005","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.08.447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}